These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23384919)

  • 1. [The clinical significance of ADAMT13 antigen change in thrombotic thrombocytopenic purpura patients by plasma exchange treatment].
    Yang P; Li YP; Wen HQ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):879-80. PubMed ID: 23384919
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombotic thrombocytopenic purpura following terbinafine therapy.
    Filanovsky K; Sigler E; Shvidel L
    J Clin Apher; 2015 Feb; 30(1):58-9. PubMed ID: 25255772
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombotic thrombocytopenic purpura--the role of ADAMTS13 assay in clinical practice.
    Duraković N; Radonić R; Gasparović V
    Coll Antropol; 2010 Sep; 34(3):1087-91. PubMed ID: 20977108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current management of thrombotic thrombocytopenic purpura.
    Kremer Hovinga JA; Meyer SC
    Curr Opin Hematol; 2008 Sep; 15(5):445-50. PubMed ID: 18695366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role for adjunctive treatment to plasma exchange in thrombotic thrombocytopenic purpura.
    Thachil J
    Nephrol Dial Transplant; 2008 Aug; 23(8):2701-2; author reply 2702-3. PubMed ID: 18403435
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity.
    Cataland SR; Jin M; Lin S; Kennedy MS; Kraut EH; George JN; Wu HM
    Br J Haematol; 2007 Nov; 139(3):486-93. PubMed ID: 17910638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney involvement in thrombotic thrombocytopenic purpura and malignant hypertension.
    Boctor FN; Prichard JW
    Transfusion; 2009 Sep; 49(9):1783-4. PubMed ID: 19735502
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful management of thrombotic thrombocytopenic purpura in a Jehovah's Witness without plasma exchange.
    Chai W; Chaudhry A; Rabinowitz AP
    J Clin Apher; 2015 Feb; 30(1):46-9. PubMed ID: 24782109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full evaluation of an acquired case of thrombotic thrombocytopenic purpura following the surgical resection of glioblastoma multiforme.
    Cataland SR; Jin M; Smith E; Stanek M; Wu HM
    J Thromb Haemost; 2006 Dec; 4(12):2733-7. PubMed ID: 16972936
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical practice. Thrombotic thrombocytopenic purpura.
    George JN
    N Engl J Med; 2006 May; 354(18):1927-35. PubMed ID: 16672704
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid determination of ADAMTS13 activity improves clinical decision-making.
    Cataland SR; Jin M; Wu HM
    Am J Hematol; 2007 Mar; 82(3):251. PubMed ID: 16929541
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfusion medicine illustrated. Massive hemolysis due to thrombotic thrombocytopenic purpura in a patient with AIDS.
    Adamski J; Marques MB
    Transfusion; 2012 Jul; 52(7):1408-9. PubMed ID: 22780894
    [No Abstract]   [Full Text] [Related]  

  • 13. Serial ADAMTS13 measurements during initial plasma exchange therapy guide decisions for management of unresponsive thrombotic thrombocytopenic purpura.
    van der Veen BS; Besseling R; Hoogendoorn M
    Transfusion; 2015 Oct; 55(10):2511-5. PubMed ID: 26308736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
    Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
    Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura.
    Moore JC; Arnold DM; Leber BF; Clare R; Molnar GJ; Kelton JG
    Vox Sang; 2007 Aug; 93(2):173-5. PubMed ID: 17683362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of changes of anti-ADAMTS13 after plasma exchange.
    Mannucci PM; Böhm M; Scharrer I; Scheiflinger F
    J Thromb Haemost; 2006 Jun; 4(6):1405-6. PubMed ID: 16706988
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombotic thrombocytopenic purpura mimicking an acute meningoencephalitis.
    Tovoli F; De Giorgio R; Fabbri A; Serra M; Caio G; Grasso V; Felicani C; Barbara G; Volta U
    Acta Clin Belg; 2011; 66(1):55-6. PubMed ID: 21485766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic thrombocytopenic purpura in childhood.
    Bouw MC; Dors N; van Ommen H; Ramakers-van Woerden NL
    Pediatr Blood Cancer; 2009 Oct; 53(4):537-42. PubMed ID: 19544391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of rituximab and concurrent plasma exchange in the treatment of thrombotic thrombocytopenic purpura.
    Hull MJ; Eichbaum QG
    Clin Adv Hematol Oncol; 2006 Mar; 4(3):210-4; discussion 217-8. PubMed ID: 16728930
    [No Abstract]   [Full Text] [Related]  

  • 20. An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura.
    Cataland SR; Jin M; Ferketich AK; Kennedy MS; Kraut EH; George JN; Wu HM
    Br J Haematol; 2007 Jan; 136(1):146-9. PubMed ID: 17069579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.